Here is a summary slide set where expert faculty members summarize key viral hepatitis studies from AASLD 2018 in San Francisco. Use these slides to review data on newer HCV regimens, the HCV continuum of care, posttreatment HCV outcomes, HCV D+R- transplantation, NA cessation in chronic hepatitis B, and investigational HBV/HDV therapeutics.
Monday, 10 December 2018 17:32
Clinical Impact of New Viral Hepatitis Data From AASLD 2018
Written by Super User
Published in
Blogs
Download attachments:
